Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 394M | 387M | 375M | 354M | 372M | 376M |
| Cost of revenue | 296M | 292M | 285M | 267M | 277M | 279M |
| Gross profit | 97M | 95M | 90M | 86M | 95M | 97M |
| Research and development | 24M | 24M | 23M | 24M | 23M | 22M |
| Selling, general and administrative | 55M | 43M | 41M | 38M | 37M | 39M |
| Operating expenses | 86M | 71M | 66M | 69M | 63M | 64M |
| Operating income | 11M | 24M | 24M | 17M | 32M | 33M |
| Pre-tax income | 8M | 21M | 3M | 2M | 19M | 28M |
| Income tax | 3M | 6M | 2M | 2M | 3M | 10M |
| Net income | 4M | 15M | 477,000 | −128,000 | 16M | 19M |
| Earnings per share | 0.14 | 0.49 | 0.02 | 0.00 | 0.51 | 0.60 |
| Earnings per share, diluted | 0.14 | 0.49 | 0.02 | 0.00 | 0.51 | 0.60 |
| Weighted average shares | 31M | 30M | 31M | 31M | 31M | 32M |
| Weighted average shares, diluted | 31M | 31M | 31M | 31M | 31M | 32M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 177M | 161M | 154M | 128M | 163M | 134M | 151M | 123M |
| Receivables | 307M | 281M | 291M |
| Metric | 31/03/2026 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|
| Operating cash flow | −5M | −13M | — | — |
| Depreciation and amortisation | 14M | 13M | 13M | 13M |
| Share-based compensation | 3M | 3M | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 295M |
| 284M |
| 258M |
| 271M |
| 265M |
| Inventory | 257M | 253M | 253M | 248M | 236M | 227M | 234M | 214M |
| Current assets | 826M | 777M | 786M | 759M | 764M | 684M | 737M | 690M |
| Property, plant and equipment | 261M | 271M | 257M | 262M | 253M | 253M | 254M | 246M |
| Goodwill | 108M | 109M | 109M | 109M | 102M | 100M | 105M | 102M |
| Total assets | 1.43B | 1.40B | 1.38B | 1.36B | 1.34B | 1.25B | 1.30B | 1.24B |
| Current liabilities | 418M | 404M | 400M | 377M | 353M | 340M | 365M | 326M |
| Long-term debt | 219M | 189M | 189M | 209M | 262M | 220M | 222M | 222M |
| Total liabilities | 714M | 676M | 663M | 662M | 698M | 631M | 637M | 600M |
| Equity | 716M | 720M | 718M | 700M | 647M | 617M | 661M | 640M |
| Shares outstanding | 31M | 31M | 31M | 31M | 31M | 31M | 31M | 31M |
| Shares issued | 31M | 31M | 31M | 31M | 31M | 31M | 31M | 31M |
| Capital expenditure | 6M | 15M | — | — |
| Investing cash flow | −6M | −11M | — | — |
| Financing cash flow | 28M | 41M | — | — |